SC
SYNH

Steph & Co’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Steph & Co’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-4,684
Closed -$167K – 247
2023
Q1 		$167K Hold
4,684
– – 0.1% 110
2022
Q4 		$172K Buy
+4,684
New +$185K 0.11% 112

Other funds holding SYNH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Steph & Co's SYNH Position: Q2 2023 in Review

Steph & Co sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2023, closing a stake of 4,684 shares — an estimated $167K sold.

Steph & Co first reported a position in SYNH in Q4 2022 and held it in 2 quarters. The position peaked at $172K in Q4 2022. 317 funds tracked by Wall St. Rank hold SYNH as of Q2 2023.

  • Steph & Co reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • Steph & Co sold 4,684 Syneos Health, Inc. Class A Common Stock shares in Q2 2023, an estimated $167K.
  • Steph & Co first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2022 and held it in 2 quarters.
  • Steph & Co's Syneos Health, Inc. Class A Common Stock position peaked at $172K in Q4 2022.
  • 317 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2023.

Based on Steph & Co's 13F filing for Q2 2023, filed 14 Jul 2023.